loadpatents
name:-0.019944190979004
name:-0.023284912109375
name:-0.0037708282470703
Banville; Jacques Patent Filings

Banville; Jacques

Patent Applications and Registrations

Patent applications and USPTO patent grants for Banville; Jacques.The latest application filed is for "imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (par4) inhibitors for treating platelet aggre".

Company Profile
3.21.20
  • Banville; Jacques - Saint-Hubert CA
  • Banville; Jacques - Montreal CA
  • Banville; Jacques - St-Hubert CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
Grant 10,822,343 - Banville , et al. November 3, 2
2020-11-03
Imidazothiadiazole And Imidazopyrazine Derivatives As Protease Activated Receptor4 (par4) Inhibitors For Treating Platelet Aggre
App 20200123160 - Banville; Jacques ;   et al.
2020-04-23
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation
Grant 10,428,077 - Banville , et al. October 1, 2
2019-10-01
Imidazopyridazine and imidazothiadiazole compounds
Grant 10,214,544 - Banville Feb
2019-02-26
Imidazothiadiazole And Imidazopyrazine Derivatives As Protease Activated Receptor4 (par4) Inhibitors For Treating Platelet Aggregation
App 20180305376 - Banville; Jacques ;   et al.
2018-10-25
Imidazopyridazine And Imidazothiadiazole Compounds
App 20180237457 - BANVILLE; Jacques
2018-08-23
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Grant 10,047,103 - Banville , et al. August 14, 2
2018-08-14
Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Grant 9,862,730 - Lawrence , et al. January 9, 2
2018-01-09
Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
Grant 9,688,695 - Banville , et al. June 27, 2
2017-06-27
Imidazothiadiazole Derivatives As Protease Activated Receptor 4 (par4) Inhibitors For Treating Platelet Aggregation
App 20150133446 - Lawrence; R. Michael ;   et al.
2015-05-14
Imidazothiadiazole And Imidazopyrazine Derivatives As Protease Activated Receptor 4 (par4) Inhibitors For Treating Platelet Aggregation
App 20150094297 - Banville; Jacques ;   et al.
2015-04-02
HIV integrase inhibitors
Grant 8,039,458 - Naidu , et al. October 18, 2
2011-10-18
HIV integrase inhibitors
Grant 7,893,055 - Walker , et al. February 22, 2
2011-02-22
N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetr- ahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxam- ide as an HIV integrase inhibitor
Grant 7,511,037 - Naidu , et al. March 31, 2
2009-03-31
Substituted imidazo[1,2-a]pyrimidines as HIV viral DNA integrase inhibitors
Grant 7,494,984 - Banville , et al. February 24, 2
2009-02-24
HIV Integrase Inhibitors
App 20080004265 - Walker; Michael A. ;   et al.
2008-01-03
HIV integrase inhibitors
App 20070111984 - Naidu; B. Narasimhulu ;   et al.
2007-05-17
Bicyclic heterocycles as HIV integrase inhibitors
Grant 7,192,948 - Banville , et al. March 20, 2
2007-03-20
Bicyclic heterocycles as HIV-integrase inhibitors
App 20070049606 - Banville; Jacques ;   et al.
2007-03-01
Bicyclic heterocycles as HIV integrase inhibitors
Grant 7,176,196 - Naidu , et al. February 13, 2
2007-02-13
Bicyclic heterocycles as HIV integrase inhibitors
Grant 7,173,022 - Naidu , et al. February 6, 2
2007-02-06
Bicyclic heterocycles as HIV integrase inhibitors
Grant 7,157,447 - Naidu , et al. January 2, 2
2007-01-02
Bicyclic heterocycles as HIV integrase inhibitors
App 20060276466 - Naidu; B. Narasimhulu ;   et al.
2006-12-07
HIV integrase inhibitors
Grant 7,109,186 - Walker , et al. September 19, 2
2006-09-19
Bicyclic heterocycles as HIV integrase inhibitors
App 20060199956 - Naidu; B. Narasimhulu ;   et al.
2006-09-07
Bicyclic heterocycles as HIV integrase inhibitors
App 20050267131 - Naidu, B. Narasimhulu ;   et al.
2005-12-01
Bicyclic heterocycles as HIV integrase inhibitors
App 20050267105 - Naidu, B. Narasimhulu ;   et al.
2005-12-01
Bicyclic heterocycles as HIV integrase inhibitors
App 20050267132 - Banville, Jacques ;   et al.
2005-12-01
Alpha-amino,-thio,-oxo substituted ketones as phospholipase inhibitors
Grant 6,924,391 - Banville , et al. August 2, 2
2005-08-02
Acyl sulfonamides as inhibitors of HIV integrase
Grant 6,890,942 - Walker , et al. May 10, 2
2005-05-10
HIV integrase inhibitors
App 20050043370 - Walker, Michael A. ;   et al.
2005-02-24
Acyl sulfonamides as inhibitors of HIV integrase
App 20050004232 - Walker, Michael A. ;   et al.
2005-01-06
HIV integrase inhibitors
Grant 6,777,440 - Walker , et al. August 17, 2
2004-08-17
HIV integrase inhibitors
App 20040110804 - Walker, Michael A. ;   et al.
2004-06-10
HIV Integrase inhibitors
App 20030176495 - Walker, Michael A. ;   et al.
2003-09-18
Alpha-and beta-substituted trifluoromethyl ketones as phospholipase inhibitors
Grant 6,414,179 - Banville , et al. July 2, 2
2002-07-02
Alpha-substituted thio,-oxo trifluoromethylketones as phospholipase inhibitors
App 20020068722 - Banville, Jacques ;   et al.
2002-06-06
Alpha-and beta- substituted trifluoromethyl ketones as phospholipase inhibitors
App 20020065246 - Banville, Jacques ;   et al.
2002-05-30
Alpha-amino,-thio,-oxo substituted ketones as phospholipase inhibitors
App 20020037875 - Banville, Jacques ;   et al.
2002-03-28
Trifluoromethyl ketone analogs as selective cPLA2 inhibitors
Grant 6,350,892 - Banville , et al. February 26, 2
2002-02-26
Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors
Grant 5,663,151 - Martel , et al. September 2, 1
1997-09-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed